Impact of the COVID-19 pandemic on the utilisation and quality of antibiotic use in the Scottish primary care setting : a population-based segmented interrupted time series analysis

Al Balushi, Hayam and Kurdi, Amanj and Almutairi, Najla and Baker, Kirmanj Ismail and Amen, Karwan M and Karwi, Hardee and Seaton, Andrew and Godman, Brian (2024) Impact of the COVID-19 pandemic on the utilisation and quality of antibiotic use in the Scottish primary care setting : a population-based segmented interrupted time series analysis. Expert Review of Anti-infective Therapy. ISSN 1744-8336 (https://doi.org/10.1080/14787210.2024.2363485)

[thumbnail of Al-Balushi-etal-ERAIT-2024-Impact-of-the-COVID-19-pandemic-on-the-utilisation-and-quality-of-antibiotic-use]
Preview
 Text. Filename: Al-Balushi-etal-ERAIT-2024-Impact-of-the-COVID-19-pandemic-on-the-utilisation-and-quality-of-antibiotic-use.pdf
Final Published Version
License: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 logo
Download (453kB)| Preview

Abstract

Inappropriate use of antibiotics is expected to increase during the COVID-19 pandemic, but there are limited data on COVID-19's long-term impact. We assessed the impact of COVID-19 on the quantity and quality of antibiotic use in Scotland. A segmented interrupted time series was applied to monthly dispensed antibiotics using prescription cost analysis data from March/2019 to March/2023. Antibiotic use was quantified using the number of items dispensed/1000 inhabitants (TIDs) and defined daily dose/1000 inhabitants/day (DIDs). The quality of antibiotic use was assessed using key quality indicators including the WHO AWaRe classification, proportion of broad-spectrum and "4C"-antibiotics. Overall, for all antibiotics, there was a non-significant increase in TIDs and DIDs before the first lockdown (March/2020) (β ), but a decline in the level immediately after the first (β ) and second lockdowns (β ) (November/2020), albeit non-significant. However, a significant increase in the time trend after the second lockdown (β ) for all antibiotic classes was observed. COVID-19 had no negative impact on AWaRe utilisation, with the proportion of all antibiotics from the Access group increasing from 76% in March/2019 to 90% in March/2023. The proportion of "4C" antibiotic reduced significantly after the second lockdown. Neither the utilisation nor the quality of total antibiotic use appeared to have been significantly affected by COVID-19.

CORE (COnnecting REpositories)